Meyers, F. J., & De Gast, G. C. (2000). Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon α in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000.  (multiple letters). Clinical Cancer Research, 6(10), 4167.